PC-FACS
PCFACS Home | Issues | Advanced Search |
April 1
Severe Alzheimer's Disease Study Group. Donepezil in patients with severe Alzheimer's disease: double-blind, parellel-group, placebo-controlled study. |
Winblad B, Kilander L, Eriksson S, Minthon L, Batsman S, Wetterholm AL, Jansson-Blixt C, Haglund A |
Donepezil for Severe Alzheimer?s Disease Background: Donepezil is a cholinesterase inhibitor that slows progression of disease in individuals with mild-to-moderate Alzheimer?s disease. Few studies ha... |
>> Continue Reading |
Palliative biliary stents for obstructing pancreatic carcinoma. |
Moss AC, Morris E, Mac Mathuna P |
Biliary Stents for Pancreatic Carcinoma Background: Pancreatic carcinoma is a disease that is often asymptomatic until very late in its course. As a result, many patients present with inoperable, adv... |
>> Continue Reading |
A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the Patient journey) in patients with heart failure. |
Cleland JG, Charlesworth A, Lubsen J. Swedburg K, Remme WJ, Erhardt L, Di Lenarda A, Komajda M, Metra M, Torp-Pederson C, Poole-Wilson PA for the COMET Investigators |
Beta Blockers and QOL in Heart Failure Background: Goals in the pharmacologic treatment of patients with heart failure include improving functional status and well-being in addition to reducing morta... |
>> Continue Reading |
Seattle Heart Failure Model: Prediction of Survival in Heart Failure. |
Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M |
Prediction of Survival in Heart Failure Background: Predicting heart failure (HF) mortality is an important step in clinical decision-making and setting goals of care. Current models are impractical ... |
>> Continue Reading |
PCFACS Home | Issues | Advanced Search |
For questions regarding this publication, send an email to resources@aahpm.org or call 847/375-4712.